Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3510LO1M
Performance in the last:
Follow this Portfolio
1D 0.0 %
1W -2.1 %
2W -1.3 %
1M 1.1 %
3M -5.5 %
6M 0.9 %
9M -6.2 %
1Y -2.5 %
Alpha
-16.9%
Beta
0.72
sharpe-R
-0.02
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
1.8
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2025-02-18 07:00:57
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -17.02%
Max. DrawDown Benchmark -8.41%

This Long Only strategy aims to find promising assets to invest in for a maximum holding period of 1 Month in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 10.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
2

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 7.45% -9.54%
The percentage of cash held in the portfolio is: 92.55%
** The description of each asset is available Here

The latest 5 Compositions change

2025-02-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 7.45% -9.54%
The percentage of cash held in the portfolio is: 92.55%
New Assets Added
None
Assets Removed
Asset Action Perf %
MD Sell All 0.36%
ORGO Sell All 11.11%
Assets Rebalanced
None
2025-02-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
MD Pediatrix Medical Group, Inc. Buy 10.07% 3.36%
ORGO Organogenesis Holdings Inc. Buy 10.01% 10.51%
RGNX REGENXBIO Inc. Buy 7.45% -9.29%
The percentage of cash held in the portfolio is: 72.47%
New Assets Added
None
Assets Removed
Asset Action Perf %
ACRS Sell All -12%
Assets Rebalanced
None
2025-02-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 8.51% -13.2%
MD Pediatrix Medical Group, Inc. Buy 9.97% 1.79%
ORGO Organogenesis Holdings Inc. Buy 10% 9.91%
RGNX REGENXBIO Inc. Buy 7.36% -10.78%
The percentage of cash held in the portfolio is: 64.17%
New Assets Added
None
Assets Removed
Asset Action Perf %
AXGN Sell All -2.52%
Assets Rebalanced
None
2025-02-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
AXGN AxoGen, Inc. Buy 9.4% -2.9%
ACRS Aclaris Therapeutics, Inc. Buy 9.27% -4.4%
MD Pediatrix Medical Group, Inc. Buy 9.67% -0.14%
ORGO Organogenesis Holdings Inc. Buy 9.65% 7.21%
RGNX REGENXBIO Inc. Buy 7.98% -2.23%
The percentage of cash held in the portfolio is: 54.04%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All -15.67%
INSM Sell All 13.33%
Assets Rebalanced
None
2025-02-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
AXGN AxoGen, Inc. Buy 9.41% -1.59%
INSM Insmed Incorporated Buy 11.1% 15.99%
ACRS Aclaris Therapeutics, Inc. Buy 9.54% -0.4%
MD Pediatrix Medical Group, Inc. Buy 9.32% -2.64%
ORGO Organogenesis Holdings Inc. Buy 9.24% 3.9%
AGEN Agenus Inc. Buy 8.24% -8.62%
RGNX REGENXBIO Inc. Buy 8.2% 1.73%
The percentage of cash held in the portfolio is: 34.95%
New Assets Added
None
Assets Removed
Asset Action Perf %
AORT Sell All 1.06%
Assets Rebalanced
None
2025-02-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 9.73% 4.86%
AXGN AxoGen, Inc. Buy 9.6% 3.45%
INSM Insmed Incorporated Buy 10.96% 18.15%
ACRS Aclaris Therapeutics, Inc. Buy 9.55% 2.8%
MD Pediatrix Medical Group, Inc. Buy 9.27% -0.14%
ORGO Organogenesis Holdings Inc. Buy 9.32% 8.11%
AGEN Agenus Inc. Buy 8.9% 1.83%
RGNX REGENXBIO Inc. Buy 8.16% 4.46%
The percentage of cash held in the portfolio is: 24.51%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Sell All 71.66%
Assets Rebalanced
None
2025-02-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 9.95% 1.19%
AXGN AxoGen, Inc. Buy 9.66% -1.81%
INSM Insmed Incorporated Buy 11.11% 12.98%
NUTX Nutex Health Inc. Buy 15.09% 53.16%
ACRS Aclaris Therapeutics, Inc. Buy 9.46% -4%
MD Pediatrix Medical Group, Inc. Buy 9.78% -0.57%
ORGO Organogenesis Holdings Inc. Buy 9.36% 2.4%
AGEN Agenus Inc. Buy 8.49% -8.36%
RGNX REGENXBIO Inc. Buy 8.03% -3.1%
The percentage of cash held in the portfolio is: 9.08%
New Assets Added
None
Assets Removed
Asset Action Perf %
SIGA Sell All -9.55%
Assets Rebalanced
None
2025-02-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 9.88% 2.41%
AXGN AxoGen, Inc. Buy 9.62% -0.22%
INSM Insmed Incorporated Buy 10.71% 11.1%
NUTX Nutex Health Inc. Buy 14.38% 48.84%
ACRS Aclaris Therapeutics, Inc. Buy 9.58% -0.8%
MD Pediatrix Medical Group, Inc. Buy 9.63% -0.14%
ORGO Organogenesis Holdings Inc. Buy 9.91% 10.51%
AGEN Agenus Inc. Buy 9.02% -0.78%
SIGA SIGA Technologies, Inc. Buy 7.14% -6.42%
RGNX REGENXBIO Inc. Buy 8.13% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RGNX
Assets Removed
Asset Action Perf %
TGTX Sell All -0.69%
Assets Rebalanced
None
2025-01-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 9.95% 1.36%
AXGN AxoGen, Inc. Buy 9.64% -1.75%
INSM Insmed Incorporated Buy 11.05% 12.62%
NUTX Nutex Health Inc. Buy 12.43% 26.44%
ACRS Aclaris Therapeutics, Inc. Buy 9.63% -2%
MD Pediatrix Medical Group, Inc. Buy 10.29% 4.86%
ORGO Organogenesis Holdings Inc. Buy 10.24% 12.31%
AGEN Agenus Inc. Buy 8.69% -6.01%
SIGA SIGA Technologies, Inc. Buy 7.71% -0.78%
TGTX TG Therapeutics, Inc. Buy 8.36% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TGTX
Assets Removed
Asset Action Perf %
ESPR Sell All -14.96%
Assets Rebalanced
None
2025-01-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 9.94% 1.82%
ESPR Esperion Therapeutics, Inc. Buy 9.18% -5.98%
AXGN AxoGen, Inc. Buy 10.1% 3.51%
INSM Insmed Incorporated Buy 11.11% 13.81%
NUTX Nutex Health Inc. Buy 11.64% 19.09%
ACRS Aclaris Therapeutics, Inc. Buy 10.17% 4%
MD Pediatrix Medical Group, Inc. Buy 9.81% 0.5%
ORGO Organogenesis Holdings Inc. Buy 9.53% 5.11%
AGEN Agenus Inc. Buy 8.79% -4.44%
SIGA SIGA Technologies, Inc. Buy 7.73% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SIGA
Assets Removed
Asset Action Perf %
BLUE Sell All -20.97%
Assets Rebalanced
None
2025-01-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLUE bluebird bio, Inc. Buy 7.95% -17.94%
AORT Artivion, Inc. Buy 10.13% 4.5%
ESPR Esperion Therapeutics, Inc. Buy 8.91% -8.12%
AXGN AxoGen, Inc. Buy 10.07% 3.95%
INSM Insmed Incorporated Buy 10.79% 11.34%
NUTX Nutex Health Inc. Buy 11.68% 20.31%
ACRS Aclaris Therapeutics, Inc. Buy 10.09% 4%
MD Pediatrix Medical Group, Inc. Buy 9.69% 0%
ORGO Organogenesis Holdings Inc. Buy 9.55% 6.01%
AGEN Agenus Inc. Buy 9.13% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AGEN
Assets Removed
Asset Action Perf %
TNDM Sell All -5.5%
Assets Rebalanced
None
2025-01-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.84% 0.47%
BLUE bluebird bio, Inc. Buy 8.15% -16.73%
AORT Artivion, Inc. Buy 10.12% 3.34%
ESPR Esperion Therapeutics, Inc. Buy 9.46% -3.42%
AXGN AxoGen, Inc. Buy 9.89% 0.99%
INSM Insmed Incorporated Buy 10.34% 5.54%
NUTX Nutex Health Inc. Buy 11.61% 18.31%
ACRS Aclaris Therapeutics, Inc. Buy 9.85% 0.4%
MD Pediatrix Medical Group, Inc. Buy 9.64% -1.64%
ORGO Organogenesis Holdings Inc. Buy 9.1% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ORGO
Assets Removed
Asset Action Perf %
MDRX Sell All -6.56%
Assets Rebalanced
None
2025-01-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.65% -3.76%
BLUE bluebird bio, Inc. Buy 8.38% -16.43%
MDRX Allscripts Healthcare Solutions, Inc. Buy 9.58% -4.51%
AORT Artivion, Inc. Buy 9.98% -0.56%
ESPR Esperion Therapeutics, Inc. Buy 9.48% -5.56%
AXGN AxoGen, Inc. Buy 10.3% 2.63%
INSM Insmed Incorporated Buy 10.22% 1.84%
NUTX Nutex Health Inc. Buy 10.27% 2.16%
ACRS Aclaris Therapeutics, Inc. Buy 10.09% 0.4%
MD Pediatrix Medical Group, Inc. Buy 10.04% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MD
Assets Removed
Asset Action Perf %
ARDX Sell All 0.19%
Assets Rebalanced
None
2025-01-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.69% -4.19%
BLUE bluebird bio, Inc. Buy 8.17% -19.25%
MDRX Allscripts Healthcare Solutions, Inc. Buy 9.44% -6.67%
AORT Artivion, Inc. Buy 9.94% -1.82%
ARDX Ardelyx, Inc. Buy 10.65% 5.24%
ESPR Esperion Therapeutics, Inc. Buy 9.69% -4.27%
AXGN AxoGen, Inc. Buy 10.11% -0.05%
INSM Insmed Incorporated Buy 10.03% -0.93%
NUTX Nutex Health Inc. Buy 10.14% 0%
ACRS Aclaris Therapeutics, Inc. Buy 10.14% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NUTX
  • ACRS
Assets Removed
None
Assets Rebalanced
None
2025-01-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.65% -3.07%
BLUE bluebird bio, Inc. Buy 8.52% -14.42%
MDRX Allscripts Healthcare Solutions, Inc. Buy 9.7% -2.56%
AORT Artivion, Inc. Buy 9.66% -2.94%
ARDX Ardelyx, Inc. Buy 10.96% 10.11%
ESPR Esperion Therapeutics, Inc. Buy 9.7% -2.56%
AXGN AxoGen, Inc. Buy 9.95% 0%
INSM Insmed Incorporated Buy 9.95% 0%
The percentage of cash held in the portfolio is: 21.91%
New Assets Added
  • AXGN
  • INSM
Assets Removed
None
Assets Rebalanced
None
2025-01-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.7% -3.63%
BLUE bluebird bio, Inc. Buy 8.59% -14.72%
MDRX Allscripts Healthcare Solutions, Inc. Buy 9.82% -2.46%
AORT Artivion, Inc. Buy 9.95% -1.16%
ARDX Ardelyx, Inc. Buy 9.56% -5.06%
ESPR Esperion Therapeutics, Inc. Buy 10.08% 0%
The percentage of cash held in the portfolio is: 42.3%
New Assets Added
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2025-01-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 10% 0.36%
BLUE bluebird bio, Inc. Buy 8.5% -14.72%
MDRX Allscripts Healthcare Solutions, Inc. Buy 9.72% -2.46%
AORT Artivion, Inc. Buy 9.97% 0%
ARDX Ardelyx, Inc. Buy 9.97% 0%
The percentage of cash held in the portfolio is: 51.84%
New Assets Added
  • AORT
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2025-01-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.82% -0.82%
BLUE bluebird bio, Inc. Buy 9% -9.07%
MDRX Allscripts Healthcare Solutions, Inc. Buy 9.9% 0%
The percentage of cash held in the portfolio is: 71.29%
New Assets Added
  • MDRX
Assets Removed
None
Assets Rebalanced
None
2025-01-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.8% 0%
BLUE bluebird bio, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • TNDM
  • BLUE
Assets Removed
None
Assets Rebalanced
None
2025-01-06 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
PCRX Sell All -3.61%
Assets Rebalanced
None
2024-12-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 10.89% 3.77%
The percentage of cash held in the portfolio is: 89.11%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All 1%
MGNX Sell All -4.12%
Assets Rebalanced
None
2024-12-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.68% 4.2%
MGNX MacroGenics, Inc. Buy 10.28% 0.29%
PCRX Pacira BioSciences, Inc. Buy 11.06% 6.5%
The percentage of cash held in the portfolio is: 67.98%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -13.23%
Assets Rebalanced
None
2024-12-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.61% 7.32%
MGNX MacroGenics, Inc. Buy 10.12% 2.35%
ESPR Esperion Therapeutics, Inc. Buy 12.5% 23.55%
PCRX Pacira BioSciences, Inc. Buy 10.01% 0%
The percentage of cash held in the portfolio is: 56.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
ITGR Sell All 1.13%
RVNC Sell All -27.34%
Assets Rebalanced
None
2024-12-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 7.35% 2.73%
APLS Apellis Pharmaceuticals, Inc. Buy 10.13% 4.6%
MGNX MacroGenics, Inc. Buy 9.94% 2.65%
ESPR Esperion Therapeutics, Inc. Buy 11.7% 18.06%
RVNC Revance Therapeutics, Inc. Buy 9.81% 0%
PCRX Pacira BioSciences, Inc. Buy 9.81% 0%
The percentage of cash held in the portfolio is: 41.25%
New Assets Added
  • RVNC
  • PCRX
Assets Removed
Asset Action Perf %
ARWR Sell All -11.63%
Assets Rebalanced
None
2024-12-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 7.23% 1.47%
APLS Apellis Pharmaceuticals, Inc. Buy 10.47% 8.55%
MGNX MacroGenics, Inc. Buy 10.47% 8.53%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.58% 0.73%
ESPR Esperion Therapeutics, Inc. Buy 9.87% 0%
The percentage of cash held in the portfolio is: 51.37%
New Assets Added
  • ESPR
Assets Removed
Asset Action Perf %
FATE Sell All -6.62%
Assets Rebalanced
None
2024-11-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 7.32% 2.95%
APLS Apellis Pharmaceuticals, Inc. Buy 10.07% 4.63%
MGNX MacroGenics, Inc. Buy 10.31% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.48% 0%
FATE Fate Therapeutics, Inc. Buy 10.48% 0%
The percentage of cash held in the portfolio is: 51.33%
New Assets Added
None
Assets Removed
Asset Action Perf %
NEOG Sell All NA
Assets Rebalanced
None
2024-11-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
NEOG Neogen Corporation Buy 7.41% -1.39%
ITGR Integer Holdings Corporation Buy 7.32% 2.95%
APLS Apellis Pharmaceuticals, Inc. Buy 10.07% 4.63%
MGNX MacroGenics, Inc. Buy 10.31% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.48% 0%
FATE Fate Therapeutics, Inc. Buy 10.48% 0%
The percentage of cash held in the portfolio is: 43.92%
New Assets Added
  • ARWR
  • FATE
Assets Removed
Asset Action Perf %
HCSG Sell All 13.06%
Assets Rebalanced
None
2024-11-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 14.69% 10.78%
NEOG Neogen Corporation Buy 7.54% -1.19%
ITGR Integer Holdings Corporation Buy 7.33% 1.48%
APLS Apellis Pharmaceuticals, Inc. Buy 9.78% 0%
MGNX MacroGenics, Inc. Buy 9.78% 0%
The percentage of cash held in the portfolio is: 50.88%
New Assets Added
  • APLS
  • MGNX
Assets Removed
None
Assets Rebalanced
None
2024-11-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 14.17% 6.67%
NEOG Neogen Corporation Buy 7.98% 4.46%
ITGR Integer Holdings Corporation Buy 7.31% 0.99%
The percentage of cash held in the portfolio is: 70.54%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Sell All 18.73%
Assets Rebalanced
None
2024-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 9.43% 17.66%
HCSG Healthcare Services Group, Inc. Buy 13.87% 3.74%
NEOG Neogen Corporation Buy 8.09% 5.23%
ITGR Integer Holdings Corporation Buy 7.11% -2.37%
The percentage of cash held in the portfolio is: 61.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All -10.08%
MDRX Sell All -7.2%
Assets Rebalanced
None
2024-11-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 9.36% 17.18%
HCSG Healthcare Services Group, Inc. Buy 14.05% 5.39%
NEOG Neogen Corporation Buy 7.8% 1.81%
MGNX MacroGenics, Inc. Buy 8.11% -7.75%
ITGR Integer Holdings Corporation Buy 7.07% -2.62%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.33% -5.24%
The percentage of cash held in the portfolio is: 42.28%
New Assets Added
None
Assets Removed
Asset Action Perf %
RGEN Sell All -17.11%
VREX Sell All 13.22%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings